Brown Brothers Harriman & Co. Has $53,000 Holdings in Humana Inc. (NYSE:HUM)

Brown Brothers Harriman & Co. trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 78.6% in the third quarter, HoldingsChannel reports. The firm owned 167 shares of the insurance provider’s stock after selling 615 shares during the period. Brown Brothers Harriman & Co.’s holdings in Humana were worth $53,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of HUM. Swedbank AB acquired a new stake in shares of Humana in the first quarter valued at $37,174,000. Atria Investments Inc raised its stake in shares of Humana by 14.5% in the first quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock worth $1,848,000 after acquiring an additional 673 shares during the last quarter. Cetera Investment Advisers lifted its position in shares of Humana by 249.0% during the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after purchasing an additional 14,944 shares in the last quarter. Cetera Advisors LLC grew its stake in shares of Humana by 472.1% during the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock valued at $3,501,000 after purchasing an additional 8,333 shares during the last quarter. Finally, Clear Rock Advisors LLC increased its holdings in shares of Humana by 4.0% in the first quarter. Clear Rock Advisors LLC now owns 5,131 shares of the insurance provider’s stock valued at $1,779,000 after purchasing an additional 199 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on HUM. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a report on Tuesday, October 1st. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Royal Bank of Canada lowered their price objective on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. UBS Group cut their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Finally, Stephens reissued an “equal weight” rating and set a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Trading Up 0.4 %

NYSE:HUM opened at $296.68 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50-day simple moving average is $275.60 and its 200-day simple moving average is $329.77. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $526.47. The stock has a market capitalization of $35.72 billion, a PE ratio of 26.28, a price-to-earnings-growth ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.